Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

37.76
BATS BZX Real-Time Price
As of 11:17am ET
 +0.52 / +1.40%
Today’s Change
11.57
Today|||52-Week Range
40.29
+7.89%
Year-to-Date
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Dec 04 / MotleyFool.com - Paid Partner Content
GW Pharmaceuticals (GWPH): What Awaits in Q4 Earnings?
Dec 01 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close37.24
Today’s open36.98
Day’s range36.65 - 38.50
Volume17,982
Average volume (3 months)2,942,798
Market cap$1.4B
Dividend yield--
Data as of 11:17am ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)-107.42%
Earnings growth (this year)+8.26%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book4.75

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.24-2.76%
AXONAxovant Sciences Ltd+0.03+0.21%
PBYIPuma Biotechnology I...+0.05+0.12%
TBPHTheravance Biopharma...-0.01-0.03%
Data as of 11:17am ET, 12/06/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$1.65
Annual revenue (last year)$0.00
Annual profit (last year)-$352.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
VP, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts


Search for Jobs